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ABSTRACT

Wade, Cameron S. M.S., Purdue University, May 2016. Biochemical Analysis of a
Prokaryotic Deubiquitinase from Escherichia Coli. Major Professor: Chittaranjan Das.
ElaD is a cysteine protease found in Escherichia coli (E. coli) and has been shown
to function as a deubiquitinating enzyme (DUB). However, ubiquitin and the
ubiquitination system are exclusive to eukaryotic cells. This indicates that ElaD may be
used when the bacteria come in contact with a eukaryotic cell. This explains its presence
in the intestinally infective strains of E. coli. For the invasive strains of E. coli,
membrane fusion and phagosome formation is used for entry of the infective cell into the
host cell. In order to counteract this, ubiquitination, the eukaryotic cell’s first defense
mechanism, is used to signal for degradation of the phagosome. The phagosome is
signaled for degradation by the host via adornment of the phagosome with Lys63-linked
ubiquitin chains. We hypothesize that ElaD is used to neutralize ubiquitination of the
phagosome and prevent destruction of the bacteria. With this hypothesis in mind we seek
to examine the substrate preference of the DUB using diubiquitin substrates of defined
linkage types. In addition we wish to understand the role of the active-site loop in
determining selectivity of the DUB for ubiquitin over a ubiquitin-like modifier Nedd8.
Through biochemical analysis of diubiquitin chain types we are able to establish a
preference for Lys63 and Lys11-linked diubiquitin over Lys48-linked diubiquitin. The

xi
ability to deubiquitinate polyubiquitinated green fluorescent protein (GFP-Ubn) shows
ElaD can completely remove ubiquitin from ubiquitinated proteins. The preference for
Lys63-linked diubiquitin and the ability to cleave ubiquitin chains from GFP-Ubn is
consistent with ElaDs deubiquitination activity at the phagosome.
A previously studied bacterial DUB, SdeA from Legionella Pneumophilia, has
both deubiquitinating and deneddylating abilities. Unlike SdeA, ElaD shows a strong
preference for ubiquitinated substrates over neddylated substrates. The crystal structure
of SdeA shows that a seven residue loop (L6), adjacent to the active site cleft, interacts
with substrates, via a conserved residue between ubiquitin and Nedd8 (Gln40). ElaD,
however, has a predicted two residue loop at an equivalent location. This gives rise to a
hypothesis that the loop in ElaD may play a role in substrate selection. To gather insight
into the possible role of the loop in substrate recognition and selectivity, a chimeric
mutant of ElaD, containing the L6 loop of SdeA (ElaD L6), is compared with wild type
ElaD (ElaD wt). The activity toward a Nedd8 substrate was increased in ElaD L6
relative to ElaD wt, although the overall activity for diubiquitin was reduced in ElaD L6.
This indicates that the L6 loop insertion contributes to Nedd8 binding. To probe the
validity of this, a mutation was made at the conserved Gln40 of ubiquitin in a diubiquitin
substrate. The activity of ElaD L6 toward the mutant substrate was examined relative to
the wild type substrate. ElaD L6 exhibited more activity toward the mutant substrate
than to the wild type substrate suggesting that the inserted loop does in fact make contact
with ubiquitin, therefore possibly Nedd8. Together all these data indicate that the small
loop in ElaD contributes to substrate affinity and selectivity.
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CHAPTER 1

1.1

INTRODUCTION

Ubiquitination

The ubiquitin system encompasses one of the largest post translational
modification systems within eukaryotic cells.1 Ubiquitin is a 76 amino acid protein used
by the cell for identification and translocation of cellular proteins. The target protein
must have a free amine group, typically a lysine, to form a covalent isopeptide bond with
the C-terminal Glycine 76 (Gly76) of ubiquitin, for ligation to take place.1,2 The process
of ubiquitination involves ubiquitin activating enzymes (E1), ubiquitin conjugating
enzymes (E2), and ubiquitin ligases (E3).1,2 The activation of ubiquitin is an adenosine
triphosphate (ATP) dependent reaction, which involves the recruitment of either one or
two ubiquitin molecules to one of the two E1’s present in human eukaryotic cells, in most
cases ubiquitin-like modifier-activating enzyme 1 (UBA1). Ubiquitin reacts with ATP to
form an adenylated ubiquitin. Next adenylated ubiquitin reacts with a catalytic cysteine
on the E1 to form a thioester linkage between the C-terminus of ubiquitin and the
cysteine of the E1, this is considered a “charged” E1.2 The catalytic cysteine from the E2
relieves the ubiquitin from the E1 and forms a thioester linkage similar to the E1.2 The
E3 interacts with the protein targeted for ubiquitination and the charged E2, to catalyze a
transfer of the ubiquitin from the E2 to the target protein.2,3 This can happen through two
different pathways, using either a single step transfer directly from the E2 to the substrate
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performed by really interesting new gene (RING) E3 ligases, or a two step transfer from
the E2 to the E3, then from the E3 to the substrate performed by homologous to the E6AP carboxyl terminus (HECT) E3 ligases.2–4 (Figure 1.1)
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Figure 1.1 Mechanism of Ubiquitination. Ubiquitin activating enzyme (E1),
ubiquitin conjugating enzyme (E2), ubiquitin ligase (E3), ubiquitin (Ub),
substrate to be ubiquitinated (S).

The addition of a single ubiquitin molecule on a protein is one way that
ubiquitination can proceed, it can undergo multi-monoubiquitination as well. Ubiquitin
can also ligate to another ubiquitin molecule several times to form a polyubiquitin chain,
via any of the free amines on the 7 lysine residues of ubiquitin, as well as the N-terminus
on the first methionine residue.1 The different linkages of ubiquitin have different effects
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on the transfer of substrates within a cell. Some examples of these linkages include:
ubiquitin linked via lysine 63 (K63) is most commonly used for lysosomal trafficking,
lysine 48 (K48) is used for trafficking proteins to the proteasome, lysine 11 (K11) is best
known for cell cycle regulation, and methionine 1 (M1) plays a role in the immune
inflammatory response via Nuclear Factor kappa B (NF-κB).1,2,5 These chains can be
either homotypic or heterotypic. In homotypic chains, linkages are the same all the way
throughout the chain. While in heterotypic chains, there are multiple types of linkages
throughout the chain. Linkages can be branched or forked, where the chain type changes
between the linkages or where multiple different chain types of ubiquitin are bound to the
same ubiquitin molecule respectively.1,2 (Figure 1.2)
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Figure 1.2 Ubiquitin Chain Types.
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This method of post-translational modification is not exclusive to ubiquitin, it is
also seen in other proteins such as neural precursor cell expressed developmentally downregulated protein 8 (Nedd8) and small ubiquitin-related modifier 2 (SUMO2)1,6–8 These
are termed ubiquitin like proteins (Ubls), since they have similar structure and
mechanisms to ubiquitin.6,7,9 (Figure 1.3) In some cases enzymes that interact with
ubiquitin also interact with Ubls.6,9

Figure 1.3 Structure of Ubiquitin Like Proteins. (1UBQ) Ubiquitin, (1NDD)
Nedd8, SUMO-2 (1WM3), ISG15 (1Z2M).

1.2

Deubiquitination

Deubiquitinating enzymes (DUBs) antagonize the ubiquitination system by
cleaving the isopeptide bond between the free amine of the target residue, most
commonly a lysine residue, and the C-terminus of the last residue of ubiquitin.1,10 There
are two main families of DUBs: cysteine proteases, which use a catalytic triad containing
a cysteine, histidine, and aspartate/asparagine/or glutamate to hydrolyze the isopeptide
bond, and metallo proteases that use a metal coordinating site to catalyze the hydrolysis
of the isopeptide bond.10 The subclasses of proteases within the cysteine protease family
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consists of ubiquitin specific protease (USP), ovarian tumor domain containing protease
(OTU), ubiquitin C-terminal hydrolase (UCH), and Machado Josephin domain protease
(MJD).10 The metallo protease family only consists of one subclass called the
Jab1/Mov34/Mpr1 Pad1 N-terminal+ containing protease (JAMM).10
Each class of DUB has different characteristics and activity. For example, the
UCH class of enzymes is shown to primarily cleave ubiquitin from a substrate molecule,
rather than cleave the isopeptide bond between chains of ubiquitin, due to a catalytic
crossover loop.10,11 Along with different methods of deubiquitination, the members of
deubiquitinases possess different ubiquitin binding domains (UBDs), such as ubiquitinassociated domains (UBAs), ubiquitin interacting motifs (UIMs), and zinc finger
ubiquitin binding domains (ZnFs). These domains are used to better stabilize the
ubiquitin in a conformation more favorable for catalysis and have an overall effect on rate
and specificity.12,13 DUBs can be used in combination with the ubiquitination system to
regulate cell cycle, protein degradation, and immune response within the eukaryotic
cell.1,10
As there are enzymes that catalyze the addition of Ubls there are also enzymes
that remove Ubls from proteins. These are termed ubiquitin like specific proteases
(ULP), and the majority are specific to their respective Ubl and do not interact with other
Ubls or ubiquitin.9 There are, however, some cases of cross-reactivity that allow either
ULPs or DUBs to interact with non-canonical substrates. This is the case for papain-like
protease from severe acute respiratory syndrome coronavirus that has a reactivity for both
ubiquitin and another Ubl, interferon stimulated gene 15 (ISG15).14
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1.3

Escherichia coli

Prokaryotes use an array of effector proteins to modulate the actions of host cells,
these are used to promote the survival of the prokaryotic cell. Escherichia coli (E. coli)
has several different strains that each use unique effector proteins for their specific
mechanism of infection.15 In many cases one of the affected cellular processes is the
ubiquitination system.16,17 Enteropathogenic Escherichia coli (EPEC) and
Enterohemorrhagic Escherichia coli (EHEC) utilize a type III secretion system (T3SS), a
syringe like structure connecting the interior of the pathogenic cell and the host cell, that
transports intracellular effector proteins into the host cell.18
In the case of EPEC cells, the infecting cell arranges itself on the periphery of the
host cell and, through the T3SS, injects translocated intimin receptors (Tir) into the host
cell.18 The Tir receptors translocate to the membrane of the host cell. Tir contains
transmembrane domains that interact with the host membrane, to allow the intimin
receptor to be exposed to the extracellular space. Intimin is exposed on the outer
membrane of the pathogenic cell. In this case during the interaction of Tir to intimin, a
C-terminal tyrosine is phosphorylated. The Tir-intimin interaction facilitates clustering
of Tir, leading to a signaling cascade within the host cell to promote the rearrangement of
the cytoskeleton and polymerization of actin filaments. The actin filaments form a
pedestal at the location of penetration, in order to maintain the extracellular state of the
infective cell.19–22 Upon infection, the concentration of E1 within the host cell decreases,
and as a result causes a decrease in protein ubiquitination. This causes an overall
decrease in active ubiquitin available to perform ubiquitination events.17,23,24 In the case
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of EHEC cells a ubiquitin ligase is released and Tir is not phosphorylated. This results in
an invasion of the EHEC cell into the host cell via membrane fusion. (Figure 1.4)25
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Actin
Pedestal Formation
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B

=Actin Filaments
=Effectors
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=EHEC

=T3SS

=Phosphate
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Figure 1.4 Infection Cycle of Enteropathogenic and Enterohemorrhagic
Escherichia coli. A) Infection cycle of EPEC cells in order from left to
right. Tir is phosphorylated and EPEC is not internalized. B) Infection
cycle of EHEC cells in order from left to right. NleL is an effector
secreted into the host cell. Tir is not phosphorylated and the EHEC cell
is internalized into the host cell.

For eukaryotic cells to counteract the invasion of infective bacteria an autophagy
defense mechanism is used by the host cell. When an invasive bacteria enters the host
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cell, through phagocytosis, the host cell recognizes the infective phagosome and
ubiquitinates the phagosome. These ubiquitin chains are K63-linked polyubiquitin. This
specific type of linkage is recognized by the host cell and an isolation membrane is
synthesized around the ubiquitinated phagosome. The isolated phagosome interacts with
a lysosome containing proteases to allow the proteases to enter and destroy the bacterial
cell. (Figure 1.5)6,26

Phagocytosis

Ubiquitination of
the phagosome

Phagosome
isolation

Lysosomal
attachment

Degradation

Nucleus

Figure 1.5 Eukaryotic Cell Autophagy Defense Mechanism.

1.4

Bacterial Deubiquitinases

Ubiquitin is only present in eukaryotic cells, though enzymes that act upon
ubiquitin have been seen in both eukaryotic and prokaryotic cells. An E3 ligase from E.
coli, Non-Lee-encoding Ligase (NleL), has been seen in EHEC cells but is not present in
EPEC cells, and is involved in ubiquitination events associated with the invasion of the
EHEC cells.27 A recently analyzed DUB has been shown to exist in a prokaryote,
substrate of the Dot/Icm secretion system E paralog A (SdeA), Legionella pneumophilia,
which is dual specific for both Nedd8 and ubiquitin. (Figure 1.6) SdeA is theorized to
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regulate bacterial phagosome associated ubiquitination related to degradation.28 This
occurrence may be linked to infectivity, which is the case for a prokaryotic DUB from
Salmonella typhimurium, Salmonella secreted effector L(SseL), which is a known
virulence factor.29

Figure 1.6 Crystal Structure of SdeA and Ubiquitin. A)
Interaction of Gln40 (yellow) with Asp66 (orange) and
Tyr38 magenta. B) Structure showing the full L6 loop
(orange) of SdeA (magenta) with Gln40 (yellow) of
ubiquitin (cyan). C) Rotation showing the absence of
interaction of SdeA with the canonical Ile44 (wheat) of
ubiquitin.
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1.4.1

ElaD

Virulent strains of E. coli have been shown to express ElaD, a poorly
characterized cysteine protease DUB, know to bind ubiquitin vinyl methyl ester (UbVME), a suicide inhibitor of cysteine proteases, and known to cleave ubiquitin 7-amino4-methylcoumarin (Ub-AMC), indicating the presence of deubiquitinating ability.16
ElaD is present in the intestinally infective strains of E. coli. (Table 1.1)16 The main
method of infection by E. coli cells is via its interaction with the host cell membrane to
allow for the insertion of a number of foreign proteins into the host cell, some of which
have yet to be characterized.15

Table 1.1 Strain Dependence of ElaD

Group of E. coli

Possess ElaD

Location

Enteropathogenic

Yes

Intestinal

Enterohemorrhagic

Yes

Intestinal

Enteroinvasive

Yes

Intestinal

Enteroaggregative

Yes

Intestinal

Enterotoxigenic

Yes

Intestinal

Commensal

Yes

Intestinal

Avian Pathogenic

No

Extraintestinal

Neonatal Meningitis

No

Extraintestinal

Uropathogenic

No

Extraintestinal
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Figure 1.7 Model of ElaD and Ubiquitin. A) Model of ElaD (green) using ULP1
as a reference with ubiquitin (cyan) from SdeA aligned into the catalytic site. B)
Catalytic triad (red) small loop (blue) Gln40 (yellow)

Since deubiquitinases possess additional binding domains used for specificity and
activity, the additional binding domain from SdeA, adjacent to the active site cleft, that
seems to allow SdeA to interact with both Nedd8 and ubiquitin, became a central point
for analysis. The theorized structure of ElaD showed, at an equivalent location to the
active site loop of SdeA, a small loop composed of just two glycine residues. (Figure 1.7)
In order to analyze both the action of this loop, as well as the validity of the theorized
structure, a chimeric construct of ElaD was made by inserting the seven residue loop
from SdeA between the two glycine residues of the theorized small loop of ElaD. (Figure
1.8) Through a variety of assays with different ubiquitin substrates, we analyzed the
actions of this loop as well as characterized the native actions of ElaD.
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Figure 1.8 Model of ElaD Superimposed on SdeA. Loop of SdeA
(orange) catalytic triad overlap (shown as sticks labeled with ElaD
residues) loop from model of ElaD (blue).
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CHAPTER 2

2.1

MATHERIALS AND METHODS

Creation of Genetic Constructs

2.1.1

Cloning

The wild type construct of ElaD (1-403) was amplified by Polymerase Chain
Reaction (PCR) from Rosetta cells. (Appendix A) A scrape of Rosetta cells was
combined into a PCR pre-mix tube with 1µL of 10µM full length (fl) forward (fwd)
primer, 1µL of 10µM fl reverse (rev) primer and filled to 20µL with ddH2O.(Bioneer) A
BioRad thermocycler was used to perform the reaction and the product was confirmed
using agarose gel electrophoresis. (Figure 2.1) The PCR product was cleaned using a
Qiagen QIAprep Spin Miniprep Kit and following the manufacturers protocol. The
cleaned PCR product and the PGEX-6P-1 vector were digested with BamHI and XhoI
using a mastermix containing 38.5µL of ddH2O, 7.7µL of New England Biolabs(NEB)
Buffer 3.1 (100mM NaCl, 50mM Tris-HCl, 100mMMgCl2, 100µg/ml BSA, pH 7.9),
1.4µL of BamHI, and 1.4µL of XhoI. The digestions were run at a 2.3:1 ratio, of volume
of mastermix to volume of prepped DNA, with total volumes of 30µL for the vector
mixture and 10µL for the insert mixture. The tubes were incubated at 37oC for 4 hours,
1µL of Calf Intestinal Phosphatase (CIP) was added to the vector tube and was left to
incubate one additional hour at 37oC, while the insert tube was placed on ice. After
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digestion, the mixtures were cleaned using the Qiagen QIAprep Spin Miniprep Kit
following the protocol from the manufacturer. The cleaned digestion products were used
for ligation with two tubes each containing 1µL cleaned vector, 1µL of NEB T4 ligase
buffer (50mM Tris-HCl, 10mM MgCl2, 1mM ATP, 10mM DTT, pH 7.5), 0.4µL
T4ligase, 4µL of ddH2O; in one tube (the ligation tube) 3µL of the cleaned digested insert
was added, in the other tube 3µL additional of ddH2O was added to make a control, and
incubated at 16oC for 16hrs. The entire ligation mixture was transformed into DH5α cells
by heat shock of 43oC for 45 seconds and plated onto Luria Broth (LB) agar plates
containing ampicillin (AMP). A colony from the plates was taken to create a mini prep
sample using the Qiagen QIAprep Spin Miniprep Kit and following the manufacturer’s
protocol. Test digestion of the mini-prepped samples were run on agarose gels to identify
the presence of the insert and vector in the mini-prepped sample.

2.1.2

Mutagenesis

Mutant constructs of wild type ElaD (wt) were made using PCR and mutagenesis
primers (Appendix). The construct of ElaD wt in PGEX-6P-1 was used as the template
for mutagenesis. The PCR mixture was similar to cloning except 2µL of template was
used instead of a scrape of Rosetta cells. A BioRad thermocycler was used to perform
the reaction using a different protocol than for Cloning. (Figure 2.1) After PCR 1µL of
DPN1 was added to the tubes and incubated at 37oC for 3hrs. The entire tube was
transformed into DH5-α cells using heat shock at 43oC and plated using AMP as the
antibiotic. Colonies were selected from the plate and mini-prepped as before and
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sequenced. The sample with the correct sequence was transformed into Rosetta cells
using heat shock at 43oC.

100

A

90
80

Temperature ( C)

70
60
50
40
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20
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0

(1x)
95oC for 5 min

100
90

Cycle Time

(25x)
95oC for 1 min
55oC for 1 min
72oC for 2 min

(1x)
72oC for 10 min
4oC for ∞

B

80

Temperature ( C)

70
60
50
40
30
20
10
0

(1x)
95oC for 5 min

Cycle Time

(25x)
95oC for 1 min
55oC for 1 min
72oC for 10 min

(1x)
72oC for 10 min
4oC for ∞

Figure 2.1 Polymerase Chain Reaction Protocol. A) Protocol for cloning B)
Protocol for mutagenesis

2.1.3

Loop Swap From SdeA Inserted into ElaD wt

For insertion of the L6 loop of SdeA into the theoretical loop of ElaD, ElaD wt
was used as the template for PCR. 2µL of the template, 1µL fl fwd primer, 1µL fl rev
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primer, 1µL fwd L6 primer, 1µL rev L6 primer, and fill to 20µL with ddH2O.(Bioneer)
A BioRad thermocycler was used to perform the reaction using the same protocol as
Mutagenesis and the product was confirmed using agarose gel electrophoresis. 2µL of
the first reaction were used as template for the second reaction along with 1µL of the fl
forward primer and 1µL of the fl rev primer. A BioRad thermocycler was used to
perform the reaction using the same protocol as Cloning and the product was confirmed
using agarose gel electrophoresis. The band at the correct molecular weight was then
excised using the bioneer gel purification kit. The purified DNA and vector were
digested and ligated using the protocol outlined in the cloning section.

2.2

Expression and Solubility

The mini-prep sample was transformed into Rosetta expression cells similar to
DH5α. Small scale expression and solubility tests were performed on colonies from the
plate. Overnight cultures were made using 5mL of LB, 5µL of 1000x AMP, and a scrape
of a colony from the plate, were grown overnight at 37oC for 16-18 hours. For each of
the cultures two more cultures were made, one for uninduced and one for induced using
5mL of LB, 5µL of 1000x AMP, and 50µL of the overnight in each tube and incubate for
4 hours at 37oC. The samples were induced with the addition of 300µL of 1M Isopropyl
β-D-1-Thiogalactopyranoside (IPTG) and incubated at 18oC for 12-16 hours. The
samples were centrifuged at 3,500xg for 10 minutes at 4oC to pellet the cells, the
supernatant was decanted and the pellet was resuspended in 1mL of Phosphate Buffered
Saline (1xPBS,) (150mM NaCl, 400mM KCl, 5mM PO42-, pH 7.4). 10µL of sample was
removed from each tube followed by the addition of 5µL of Sodium Dodecyl Sulfate

17
Polyacrylamide Gel Electrophoresis (SDS-PAGE) sample buffer (10%SDS, 0.3125M
Tris-HCl, 25% 2-mercaptoethanol, 0.01% bromophenol blue, 1M sucrose) to each of
those samples. The induced samples were sonicated and spun down, and 10µL of
supernatant was collected and 5µL of SDS-PAGE sample buffer was added to the
sample. The samples were run on a SDS-PAGE gel and stained with coomassie brilliant
blue (CBB) stain. (Figure 2.2) The protein was expressed and soluble leading to
verification to proceed to a larger 6L protein purification.

Figure 2.2 Expression and Solubility
Test for GST-ElaD wt. Uninduced
(U), Induced (I), Supernatant (S).

2.3

Affinity Purification

To purify the proteins based upon their respective tags or charges, different
methods of affinity purification were used.
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2.3.1

GST Tagged Protein Purification

A scrape from the glycerol stock of cells expressing the protein of interest in
PGEX-6P-1 was used to inoculate a starter culture of 100mL of LB media and 100µL of
1000x AMP for 12-16hrs at 37oC. 10mL of the started culture and 1mL of 1000x AMP
was used to inoculate each of the 6 1L containers and incubate at 37oC until reaching an
OD600 between 0.4-0.6. These were induced with IPTG and incubated at 18oC for 1216hrs. The cells were centrifuged at 7000xg for 7min at 4oC and supernatant was
removed until all of the cells were pelleted. The cells were resuspended in sufficient
1xPBS and left to incubate on ice with lysozyme for 30min. The resuspended cells were
lysed with a French Press until sufficient lysis was achieved. The lysate was centrifuged
at 100,000xg for 1hr at 4oC. The supernatant was transferred onto the GST column
equilibrated with column buffer (1xPBS). The column was washed with the column
buffer to remove undesired proteins. The desired protein was removed using GST
column elution buffer (0.25M Tris, 0.5M KCl, 0.01M reduced glutathione). Samples of
each of these steps were confirmed using SDS-PAGE and stained with CBB. (Figure 2.3)
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Figure 2.3 GST-ElaD C313A GST Purification. (S) Supernatant from
ultracentrifugation, (FT) Flow Through, (W) Wash, (E) Elution (AD)
After Dialysis, (Sub) Subtraction, (C) Concentrated Subtraction.

2.3.1.1

Purification after Removal of GST Tag
PreScission protease (GE Healthcare Life Science) was added to the elution

sample to remove the GST tag and dialyzed in a 4L container of dialysis buffer(150mM
NaCl, 400mM KCl, 1mM DTT, 5mM PO42-, pH 7.4) for 4-6 hours, and was transferred
to another 4L container of dialysis buffer for another 4-6 hours to remove the reduced
glutathione from the elution. The dialyzed sample was run again on a cleaned and
equilibrated glutathione sepahrose column in order to remove the free GST and
PreScission protease (GE Healthcare Life Sciences). This solution was concentrated
down to a volume of less than 4 mL. The concentrated sample was further purified by
size exclusion chromatography on an equilibrated Hiload SuperdexTM 75 size exclusion
column (S75) using S75 buffer (50mM Tris-HCl pH7.4, 50mM NaCl, 1mM DTT).
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Samples of the corresponding peak were analyzed via SDS-PAGE and stained with CBB.
(Figure 2.4) The purified protein was concentrated to a volume less than 1mL, the
concentration was determined using a spectrometer at 280nm and corresponding
extinction coefficient that was calculated using Expasy. The concentrated protein was
aliquoted, flash-frozen, and stored in -80oC freezer.

Figure 2.4 S75 Size Exclusion Chromatogram for ElaD C313A. Size
Exclusion chromatogram of the ElaD C313A concentrated subtraction
sample, absorbance at 280nm (blue), absorbance 260nm (red), absorbance
baseline (fuchsia). Gel samples that were pooled from fractions B10 to C6.

2.3.2

Ubiquitin Purification

A scrape from the glycerol stock of the cells expressing Monoubiquitin from
PRSFduet cells were used to inoculate a starter culture of 100mL of LB media with
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Kanamycin for 12-16hrs at 37oC. 10mL of the starter culture and 1mL of 1000x
Kanamycin was used to inoculate each of the 6 1L containers and was incubated at 37oC
until an OD600 between 0.4-0.6 was reached. These cultures were induced with IPTG and
incubated at 18oC for 12-16hrs. The cells were centrifuged at 7000xg for 7min at 4oC
and supernatant was decanted until all of the cells were pelleted. The cells were
resuspended in sufficient Buffer A (50mM NaC2H3O2, 2mM DTT, pH 4.5) and left to
incubate on ice with lysozyme for 30min. The resuspended cells were lysed via French
Press until sufficient lysis was achieved. The lysate was heated to 80oC for 5 minutes
and centrifuged at 100,000xg for 1hr at 4oC. The supernatant was run on an equilibrated
SP-Sepharose (GE Healthcare Life Sciences) column and washed twice with Buffer A.
Elution was performed on a gradient scale using percentages of Buffer B (50mM
NaC2H3O2, 2mM DTT, 1M NaCl, pH 4.5) in 5% increments from 5% to 50% with 5x
5mL fractions collected at each concentration, the final elution consisted of 9x 5 mL
fractions at 100% Buffer B. The third fraction from each concentration was analyzed
using SDS-PAGE and stained with CBB. The fractions containing ubiquitin were pooled
and further purified via by S75 Size Exclusion chromatography. The S75 chromatogram
was analyzed and samples of the corresponding fractions were analyzed with SDS-PAGE
and stained with CBB, the best fractions were pooled and concentrated. (Figure 2.5)
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Figure 2.5 Ubiquitin Purification Using Ion Exchange. A) SDS-PAGE gel of
samples from Ion Exchange using concentrations of Buffer B, (FT)
flowthrough, (W1) Wash 1, (W2) Wash 2. B) Size Exclusion chromatogram
of the concentrated ubiquitin elutions, absorbance at 280nm (blue),
absorbance 260nm (red), absorbance baseline (fuchsia). C) SDS-PAGE gel of
fractions C6 to D10 with C9 to D7 showing ubiquitin bands.
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2.4

2.4.1

Activity Assays

Ubiquitin-Propargylamide Shift Assay

ElaD wt, ElaD C313A, and ElaD L6 were incubated at 25µM of enzyme with
excess Ubiquitin-Propargylamide (Ub-Pro) (Ubiquitin-Propargylamide was prepared by
Aditya Babar of the lab).30 This was analyzed using SDS-PAGE and stained with CBB.
The presence of an ~8kDa shift in the molecular weight of the protein, indicated the
covalent linkage of Ub-Pro to the protein of interest.

2.4.2

Diubiquitin Cleavage Assay

Cleavage specificity assays were performed at concentrations of 1µM of ElaD wt
or ElaD L6 and 20µM of the diubiquitin chain (M1, K11, K48, and K63) at a total
volume of 20µL at room temperature (the diubiquitin chains were prepared by David
Miller, Aditiya Babar, Rashmi Shrestha, and Michael Sheedlo of the lab).31–34 The
reaction was quenched with SDS-PAGE sample buffer to obtain both 0hr and 1hr time
points, the samples were analyzed using SDS-PAGE and stained with CBB.
The diubiquitin chain preference assay was performed with 100nM ElaD wt and
20µM of the diubiquitin chains (M1, K11, K48, and K63) at a total volume of 20µL at
room temperature. The reaction was quenched with SDS-PAGE sample buffer to obtain
both 0min and 10min time points, the samples were analyzed using SDS-PAGE and
stained with CBB.
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A mutant version of K63 diubiquitin with a Q40A mutation was used to
determine the binding of the loop to the Q40 position of ubiquitin (the K63 Q40A
diubiquitin mutant was prepared by Michael Sheedlo of the lab). 1µM of ElaD wt or
ElaD L6 and 20µM of either wild type K63 diubiquitn or K63 Q40A diubiquitin at a total
volume of 20µL at room temperature. The reaction was quenched with SDS-PAGE
sample buffer to obtain both 0hr, and 1hr time points and the samples were analyzed
using SDS-PAGE and stained with CBB.

2.4.3

Polyubiquitinated Green Fluorescent Protein Cleavage Assay

To determine physiologically relevant deubiquitination, polyubiquitinated green
fluorescent protein (GFP-Ubn) was used as a substrate (the GFP-Ubn was prepared by
Michael Sheedlo of the lab).35 The GFP-Ubn reaction was performed at 50nM of the
ElaD constructs (ElaD wt, ElaD C313A, and ElaD L6) and 2µM of the GFP-Ubn in S75
buffer. The reaction was quenched with SDS-PAGE sample buffer to obtain time points
at 0 min and 10 min for each of the constructs as well as a 0min and 10min time point for
GFP-Ubn. The samples were analyzed using SDS-PAGE.
A time point assay was performed for ElaD wt using 25nM ElaD wt and 2µM of
the GFP-Ubn in S75 buffer. The reaction was quenched with SDS-PAGE sample buffer
to obtain time points at 0, 1, 2, 4, 6, 8, and 16min. The samples were analyzed using
SDS-PAGE and stained with CBB. The bands of different polyubiquitin chains were
quantified by image-J for each of the time points.
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A concentration dependence assays was performed for ElaD L6 on the GFP-Ubn
substrate at concentrations of 100nM, 200nM, 500nM, and 1µM of ElaD L6 and 2µM of
GFP-Ubn. The reaction was quenched with SDS-PAGE sample buffer to obtain time
points at 0 and 10 min. A separate reaction was run for 24hrs at 1µM ElaD L6 and 2µM
of GFP-Ubn. The samples were analyzed using SDS-PAGE and stained with CBB.

2.4.4

Maltose Binding Protein-Nedd8-Ubiquitin Complex Cleavage Assay

To analyze the effect of the L6 mutation on the ability of ElaD to interact with
Nedd8, a construct of Nedd8-ubiquintin with a 6xhistidine maltose binding protein
(6xHis-MBP) tag (MBP-Nedd8-Ub) was used as the substrate (MBP-Nedd8-Ub was
prepared by Michael Sheedlo of the lab).36 An assay was performed for ElaD wt and
ElaD L6 constructs with 1µM of ElaD and 2µM of MBP-Nedd8-Ub filled to 20µL S75
buffer and reactions were quenched with 5µL SDS-PAGE sample buffer to obtain time
points of 0hr, 1hr, 7hr, and 24 hr. Samples were analyzed using SDS-PAGE and stained
with CBB.
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CHAPTER 3 RESULTS

3.1

Preparation of Protein

3.1.1

Cloning

To obtain the wild type construct of ElaD, Polymerase Chain Reaction (PCR) was
used to amplify the wild type gene from Rosetta cells. Rosetta is descended from the
commensal strain of E. coli, which has been shown to contain ElaD. PCR was used with
full length forward and reverse primers with the respective restriction enzyme sites for
ligation into PGEX-6P-1.16 (Figure 3.1) This showed a bright band at the correct number
of base pairs (bp), the product and the vector were each digested with the same restriction
enzymes, then ligated together to form a circular plasmid of PGEX-6P-1 containing the
wild type ElaD. The plasmid was transformed into DH5-α cells using heat shock. To
determine successful cloning the mini-prep sample was digested with the same restriction
enzymes to prove that wild type ElaD was inserted into the vector. For expression of the
protein, the mini-prepped plasmid was then transformed into Rosetta cells using heat
shock and were plated on AMP plates.
A chimeric construct of ElaD containing the interacting loop (L6) from SdeA was
made using a two step cloning method, and the band was excised after the second set of
PCR at the correct molecular weight, then digested and ligated into PGEX-6P-1. (Figure
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3.2) This construct was made to analyze the difference between the long and short loops,
and how they would affect the overall interaction with ubiquitin, as well as if the loop
would convey some interactions for the specificity of Nedd8 from its progenitor, SdeA.
The construct was sequenced to ensure that the entire insert was present, since the results
were positive the construct was transformed into Rosetta cells.

Figure 3.1 Agarose
Gel of Cloning ElaD
from Rosetta Cell.
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Figure 3.2 Agarose Gel of Cloning
ElaD L6 Chimera. (right) ElaD L6
PCR 1 contains the two halves of ElaD
with the extra bases containing the L6
insert at nearly the same size (middle)
ElaD L6 PCR 2 contains the two
halves used from PCR1, as well as the
final complete construct.

3.1.2

Mutagenesis

In order to obtain a catalytically inactive mutant, mutagenesis was performed on
ElaD to mutate cysteine 313 to an alanine (ElaD C313A). This would disrupt the
catalytic activity of the cysteine protease by removing the active sulfur group from the
catalytic triad, and abolishing the ability for hydrolysis. The results for sequencing
indicated that the single mutation was present at the correct location. The construct that
gave the best sequencing results was later used for purification of the ElaD C313A.
To understand what effect the two residue turn might have on the stability of ElaD
and its binding, mutants of Gly229 and Gly230 of the turn in ElaD were made using the
same mutagenesis protocol, and the sequencing results showed positive results for the
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mutation. The constructs that gave the best sequencing results were later used for
expression of the loop mutants.

Table 3.1 List of ElaD Constructs
Construct

Method

Description

ElaD wt

Cloning

Wild type ElaD

ElaD C313A

Mutagenesis

Catalytically inactive mutant

ElaD L6

Cloning

ElaD chimera with L6 loop from SdeA

ElaD G229A

Mutagenesis

Mutant of Gly229 to Ala of the small loop of ElaD

ElaD G230A

Mutagenesis

Mutant of Gly230 to Ala of the small loop of ElaD

ElaD G230R

Mutagenesis

Mutant of Gly230 to Arg of the small loop of ElaD

ElaD G230W

Mutagenesis

Mutant of Gly230 to Trp of the small loop of ElaD

3.1.3

Protein Expression and Solubility Test Small Scale

Multiple colonies of transformed Rosetta cells were grown in separate 5mL
overnight cultures of LB and 1mM AMP. These were used to make 3mL uninduced and
induced expression cultures, and were grown at 37oC for 4hrs. The uninduced tubes were
used to make glycerol stocks of each colony, the induced cultures were then induced with
IPTG and grown for 16hrs at 18oC. Tubes were centrifuged at 3,500xg for 10min at 4oC
and the supernatant was decanted, the pellet was resuspended in 800µL of 1xPBS.
Samples for the uninduced resuspensions were taken and the induced resuspensions were
then sonicated to shear the cell, induced samples were then taken. The induced sonicated
samples were centrifuged to pellet the debris, and samples of the supernatant were taken
for the solubility sample. These samples were run on a SDS-PAGE gel and showed an

30
induction of a band at ~26kDa for free GST as well as at ~72kDa for the wild type GSTElaD (wt) fusion construct. The expression and solubility tests showed strong expression
for the wild type GST-ElaD, and that the construct was soluble.
The same protocol was followed for the expression of all of the other constructs
of ElaD. The expression and solubility test showed that ElaD C313A and ElaD L6 were
both soluble. (Figure 3.3) This was not the case for the loop point mutants, which had a
reduced solubility comparatively. When Gly229 was mutated to Ala the solubility test
showed a complete loss in solubility of the protein. When Gly230 was mutated to Ala
some solubility was retained, however, when mutated to a larger, hydrophobic, or
charged amino acid the solubility was again lowered severely. This indicated that the
two glycine residues of the turn are important to the protein’s stability and structure.
(Figure 3.4)

Figure 3.3 Expression and Solubility Test of ElaD
C313A and ElaD L6. A) Uninduced (U), induced (I),
supernatant (S) ElaD C313A. B) ElaD L6.
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Figure 3.4 Expression and Solubility Test of ElaD Loop Point Mutants. A)
Uninduced (U), Induced (I), and Supernatant (S) ElaD G229A B) ElaD G230W C)
ElaD G230A D) ElaD G230 R.

3.1.4

Protein Purification

Wild type GST-ElaD was purified using GST purification, the samples that were
collected throughout the purification were analyzed using a SDS-PAGE gel. The elution
showed a strong band at ~72 kDa for the GST-ElaD wt and at ~26kDa for free GST.
After dialysis with PreScission Protease overnight, a band at ~42kDa formed, which
indicated the release of GST from the GST-ElaD fusion. The subtraction sample showed
a marked decrease in the GST concentration, but upon concentration of the solution
showed that GST related proteins remained. The concentrated sample was purified
further via size exclusion, and the chromatogram showed two major peaks. The second
peak was analyzed by SDS PAGE and showed an impure ElaD sample, upon
concentration the sample was then re-subtracted as before and showed a much more pure
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sample of wild type ElaD and was concentrated to 485.3µM, ElaD C313A was
concentrated to 181µM, and ElaD L6 was concentrated to 80.4µM. (Appendix B)

3.2

Assays

To analyze the different constructs of ElaD, assays were performed with different
ubiquitin related substrates. Ubiquitin-propargylamide shift assays were used to
determine if the purified protein was active. Diubiquitin cleavage assays were used to
determine the specificity and preference for a variety of common polyubiquitin chain
linkages. Diubiquitin, however, is not the most physiologically relevant for the activity
of deubiquitinases, so assays with polyubiquitinated Green Fluorescent Protein (GFPUbn), a more appropriate substrate for DUBs, were performed. Another bacterial DUB
from Legionella Pneumophilia, SdeA, has a dual-specificity to both Nedd8 and ubiquitin,
to determine the specificity of ElaD towards Nedd8 and fusion construct of Nedd8ubiquitin was used.

3.2.1

Ubiquitin-Propargylamide Shift Assay

To determine if the purified proteins were catalytically active, a reaction was
performed between the three constructs of ElaD (wild type, the catalytically inactive
mutant C313A, and the chimeric construct containing the L6 loop from SdeA) and a
suicide inhibitor of cysteine proteases, Ubiquitin-Propargylamide (Ub-Pro). A shift of
8kDa in the overnight reaction for the wild type and the L6 insertion constructs showed
that they were both catalytically active, and that the C313A mutant construct was in fact
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catalytically inactive. This showed that a 7 amino acid insertion into ElaD did not
abolish its catalytic ability. (Figure 3.5)

Figure 3.5 Ubiquitin-Propargylamide Shift Assay for ElaD
Constructs. Ubiquitin-propargylamide (Ub-Pro) ElaDubiquitin molecular weight (ElaD-Ub) ElaD molecular
weight (ElaD).

3.2.2

Diubiquitin Cleavage Assay

From the variety of polyubiquitin chains that are possible substrates for DUBs,
cleavage of the diubiquitin constructs of known function were used to determine if a
preference was evident for a specific chain linkage type. The two catalytically active
constructs of ElaD were used for diubiquitin cleavage assays with M1, K11, K48, and
K63 substrates. For ElaD wt cleavage was seen for all except M1, demonstrating that
there is either a multi-specificity or a promiscuity of the enzyme for diubiquitin chains.
At lower concentration over a smaller time period a preference was seen for the
hydrolysis of K63 and K11-linked diubiquitin over K48-linked diubiquitin, which in the
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case of K63 is used by the cells mainly for lysosomal trafficking, and in K11 is used by
the cells primarily for cell cycle regulation. (Figure 3.6)

Figure 3.6 ElaD wt Diubiquitin Cleavage Assay. 20µM diubiquitin chain
types of M1, K11, K48, K63 A) 1µM ElaD wt for 0min and 60 minute time
points diubiquitin molecular weight (2-Ub), monoubiquitin molecular weight
(1-Ub). B)100nM ElaD wt for 0min and 10 minute time points.

When ElaD L6 was incubated with the same diubiquitin chains, cleavage was
seen for K11 and K63 diubiquitin chains, though not at the same level as for ElaD wt,
however, cleavage was not seen for K48 diubiquitin within this time frame. (Figure 3.7)

Figure 3.7 ElaD L6 Diubiquitin Cleavage Assay.
1µM ElaD L6, 20µM diubiquitin chain types of
M1, K11, K48, K63 for 0min and 60 min time
points.
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To analyze the actions of the L6 loop of the ElaD L6 construct, a comparison of
the interactions of the L6 loop from SdeA was used. To determine if the same interaction
between Gln40 in ubiquitin and L6 loop in SdeA, seen in the SdeA crystal structure, was
present in the ElaD L6 construct, a mutant diubiquitin was used. By mutating glutamine
40 to alanine of K63 diubiquitin the interaction between L6 loop and Gln40 of ubiquitin,
if present, would be interrupted. ElaD wt did not show any preference between the two
K63 chains, however, ElaD L6 did show an increase in activity with K63 Q40A
diubiquitin, as compared to its activity with wild type K63 diubiquitin. (Figure 3.8)

Figure 3.8 K63 Q40A Diubiquitin Cleavage Assay. 1µM ElaD 20µM
diubiquitin for 1hr. The left half contains wild type K63 diubiquitin the right
half contains K63 Q40A diubiquitin, diubiquitin (2-Ub), monoubiquitin (1-Ub).

3.2.3

Polyubiquitinated Green Fluorescent Protein Cleavage Assay

Though ElaD may be able to hydrolyze a diubiquitin chain free in solution, that
does not directly translate to its ability to cleave a ubiquitinated protein. In order to
identify this relationship polyubiquitinated green fluorescent protein (GFP-Ubn) was
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used. GFP-Ubn is synthesized using GFP containing a degron, that causes GFP to be
ubiquitinated with a different variety of chain types and lengths.35,37 This is more
physiologically relevant since DUBs are usually used by cells to cleave ubiquitinated
proteins rather than unbound polyubiquitin chains.
The assay performed at 50nM of ElaD constructs and 2µM GFP-Ubn showed a
laddering of different lengths of ubiquitin chains in the ElaD wt construct. No cleavage
was seen in the ElaD C313A construct or the ElaD L6 construct. (Figure 3.9) Varying
the concentration of the ElaD L6 construct with the same concentration of GFP-Ubn still
did not show cleavage after 10 minutes. After 24 hrs at 1µM of ElaD L6 the GFP-Ubn
was cleaved to show mostly monoubiquitin. (Figure 3.10)

Figure 3.9 ElaD constructs GFP-Ubn Cleavage Assay. 2µM of GFPUbn and 50nM of each of the ElaD constructs at 0min and 10min
time points, polyubiquitinated GFP molecular weight (GFP-Ubn),
tetraubiquitin molecular weight (4-Ub), triubiquitin molecular
weight (3-Ub), diubiquitin molecular weight (2-Ub), monoubiquitin
molecular weight (1-Ub)
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Figure 3.10 ElaD L6 Varied Concentration and Time GFP-Ubn
Cleavage Assay. A) 100nM, 200nM, 500nM, and 1µM of ElaD L6
2µM GFP-Ubn for 0min and 10min time points. B) 1µM ElaD L6
2µM GFP-Ubn for 24 hr.

The time point assay with ElaD wt and GFP-Ubn showed a progressive increase in
cleavage of the polyubiquitinated substrate. The appearance of ubiquitin bands was
noticeable at the 2min time point, with an increase in concentration of the higher order
chains. As time increased, an increase in the concentration of lower order chains was
observed, with a decrease in the concentration of the higher order chains. However, after
16 min a band at the monoubiquitin molecular weight was still not observed. (Figure
3.11)
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Figure 3.11 ElaD wt GFP-Ubn Timepoint Assay. A) All contain 2µM of
GFP-Ubn, timpoints contain 25nM ElaD wt. diubiquitin (2-Ub),
triubiquitin (3-Ub), tetraubiquitin (4-Ub). B) Quantification of the
intensity of the bands corresponding to the ubiquitin chains versus time.

3.2.4

Maltose Binding Protein-Nedd8-Ubiquitin Complex Cleavage Assay

Two constructs of ElaD (ElaD wt and ElaD L6) were incubated with a linear
maltose binding protein-Nedd8-ubiqutin fusion construct. (Figure 3.12) Cleavage of the
ubiquitin from Nedd8 was seen in both constructs after 24 hours, but a more robust
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cleavage was seen for the ElaD L6 construct than ElaD wt at 7hr. The evolution of a
lower order band, that was not seen in the ElaD wt cleavage, was also noted. (Figure
3.13)
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Figure 3.12 Depiction of the 6xHis-MBP-Nedd8Ub Hydrolysis. The cleavage of ubiquitin from the
C-terminus of Nedd8 would result in an 8kDa
decrease in molecular weight.

Figure 3.13 ElaD Constructs 6xHis-MBP-Nedd8-Ub Cleavage Assay. 2µM of MBPNedd8-Ub and 1µM ElaD constructs were incubated for 0hr, 1hr, 7hr, and 24hr time
points.
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CHAPTER 4 DISCUSSION

4.1

ElaD Chain Linkage Preference

Invasive E. coli use a membrane fusion method of entry (phagocytosis) into the
host cell for infection.26,38 To counteract this intrusion, the host cell decorates the
phagosome containing the bacteria with K63-linked polyubiquitin chains.26 This type of
ubiquitination signals for destruction of the bacteria. The release of a DUB to remove
these chains would be able to prolong the survival of the invading bacteria in the host
cell.
ElaD wt was able to cleave K11, K48, and K63-linked diubiquitin chains, with a
preference toward K11 and K63-linked chains over K48-linked diubiquitin. ElaD wt also
displayed the ability to remove polyubiquitin chains from a ubiquitinated protein (GFPUbn). A preference for another linkage type of diubiquitin over K63-linked diubiquitin
would indicate that the purpose for ElaD was not to deubiquitinate the phagosome. This
is why, currently, we cannot decipher the main purpose of ElaD within the E. coli
lifecycle. Further studies need to be performed to obtain a clearer picture of which
linkage type is preferred.
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4.2

ElaD Loop Interactions on Substrate Selectivity

SdeA is multi-specific for both ubiquitin and Nedd8. ElaD has been
shown to also react with both, but has a much greater preference for ubiquitin than for
Nedd8. The crystal structure of SdeA bound to ubiquitin shows a seven residue
interacting loop adjacent to the active site cleft. This interacting loop makes contact with
Gln40 on ubiquitin. The conservation of Gln40 between Nedd8 and ubiquitin may be
contributing to the multi-specificity for Nedd8 and ubiquitin in SdeA. The predicted
structure of ElaD contains a two residue loop in an equivalent position to the loop of
SdeA. To increase the activity of ElaD for Nedd8, a chimeric construct of ElaD
containing the interacting loop from SdeA (ElaD L6) was made.
The ElaD L6 construct had an overall decrease in activity for all linkage types of
diubiquitin relative to ElaD wt, but the preference for K11 and K63-linked diubiquitin
over K48-linked diubiquitin was still retained. ElaD L6 was observed against an MBPNedd8-Ub construct designed to determine activity toward Nedd8. ElaD L6 had an
increased activity for the MBP-Nedd8-Ub substrate compared to ElaD wt. This indicated
that the inserted loop on ElaD L6 interacts to Nedd8 to allow for an increase in catalytic
activity. To further prove the interaction was due to the loop insertion, a mutant K63linked diubiquitin substrate was used. The conserved Gln40 on ubiquitin and Nedd8 was
shown to interact with the loop in SdeA, and was the target for mutagenesis. To remove
that interaction between the L6 loop and Gln40, a construct of Gln40Ala K63-linked
diubiquitin was used. If the binding of this residue was not involved then the activity for
ElaD L6 to the mutant substrate would have been the same as the activity for ElaD L6 to
the wild type substrate. However, the increased activity for the mutant substrate in the
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ElaD L6 enzyme demonstrated that the L6 loop insertion was playing a role in
interactions with the conserved Gln40 residue and may be inducing the increase in
activity for Nedd8.

4.3

Conclusion

SdeA and SseL are DUBs known to be virulence factors. Since ElaD is present in
intestinally invasive E. coli, and is sequentially similar to SseL, we sought to investigate
the preference of ElaD for Lys63-linked diubiquitin.28 Since diubiquitin cleavage alone
is not as physiologically relevant, a polyubiquitinated protein was used to determine the
ability to remove ubiquitin chains from a polyubiquitinated protein. The combination of
preferences for Lys11 and Lys63-linked diubiquitin, and deubiquitination ability for
ubiquitinated protein is consistent with our theory that ElaD may be able to
deubiquitinate a phagosome within the host cell. Since the preference between the two
was not established we do not have enough evidence, however, to make a concrete claim.
More studies must still be done to further differentiate the preferences.
A preference for binding ubiquitin over Nedd8 has been seen for ElaD, whereas
another bacterial DUB, SdeA, has preferences for both substrates. The crystal structure
of SdeA bound to ubiquitin showed interactions between a 7 residue loop of SdeA and
Gln40 of ubiquitin, which is conserved between ubiquitin and Nedd8. Through
comparison between ElaD wt and ElaD L6 we were able to note the role played by the
loop in activity, and specificity of the DUBs for their respective substrates. Loop
composition was also important for the overall stability of the enzyme, due to a decrease
in solubility for the ElaD loop point-mutants. The K63 Q40A diubiquitin assay showed
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that the Q40 residue interacted with the L6 insertion of ElaD L6. The activity for the
K63 Q40A diubiquitin cleavage assay for ElaD wt remained the same, these results
suggest that the interaction between ubiquitin and ElaD wt does not involve Q40 of
ubiquitin. The mode of binding ubiquitin, which is native to ElaD wt, requires a small
loop to maintain its more robust activity for ubiquitin chains. The size of the loop in this
prokaryotic DUB is necessary for the addition of the canonical ubiquitin binding domain
that conveys improved specificity for its preferred substrate.
Further studies must be conducted to more accurately differentiate the preference
between K11 and K63-linkage types. Kinetic studies using isothermal titration
calorimetry, or gel based analysis could be used to better elucidate what was the original
purpose for ElaD. If the hypothesis is correct, more studies in eukaryotic cells must be
done, using invasive E. coli, to identify how necessary ElaD is to survival of the bacteria.
Though we can understand that the small loop may not directly interact with ubiquitin, it
still plays a role in activity and specificity. The extent of how ElaD interacts with the
substrate to provide the specificity is still unknown. A crystallographic structure of each
of the ElaD constructs bound to ubiquitin and Nedd8 would better describe how the
different bacterial DUBs discriminate against their substrates. To determine other modes
of binding used by ElaD, mutation studies in different areas of ElaD may result in
changes in binding and preferences for specific linkage types of ubiquitin or chain
lengths. Understanding how ElaD binds its preferred substrate may provide new
information into the structure and function of bacterial deubiquitinases as a whole.
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Appendix A

A.1

Cloning Primers for ElaD

BamHI fl fwd:

5’ GCATGCATGGATCCATGATGGTTACAGTTGTCAGC 3’

XhoI fl rev:

5’ GCATGCATCTCGAGTTAACTCACTCTTTTGCCGGA 3’

A.2

Catalytic Mutant Primers for ElaD

C313A fwd:

5’ TACTTAAGCCAAAGTGCCGGTGCATTTGTGTG

C313A rev:

5’ GCACACAAATGCACCGGCACTTTGGCTTAAGTA 3’

A.3

3’

Loop Mutant Primers for ElaD

L6 insert fwd: 5’ GTAGGACCACACAGAGACTCCGGACACTGGATATTAGTT 3’
L6 insert rev: 5’ GGAGTCTCTGTGTGGTCCTACGCCAGTATTTATGGGGAA 3’
G229A fwd: 5’ TTCCCCATAAATACTGCCGGACACTGGATATTAGTT

3’

G229A rev:

5’ AACTAATATCCAGTGTCCGGCAGTATTTATGGGGAA

3’

G230A fwd: 5’ TTCCCCATAAATACTGGCGCACACTGGATATTAGTT

3’

G230A rev:

3’

5’ AACTAATATCCAGTGTGCGCCAGTATTTATGGGGAA

G230W fwd: 5’ TTCCCCATAAATACTGGCTGGCACTGGATATTAGTT

3’

G230W rev:

3’

5’ AACTAATATCCAGTGCCAGCCAGTATTTATGGGGAA
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G230R fwd:

5’ TTCCCCATAAATACTGGCCGACACTGGATATTAGTT

3’

G230R rev:

5’ AACTAATATCCAGTGTCGGCCAGTATTTATGGGGAA

3’
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Appendix B

B.1

Purification of ElaD wt

Figure B.1 ElaD wt Purification.
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B.2

Purification of ElaD L6

Figure B.2 ElaD L6 Purification.
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Appendix C

C.1

Computational Analysis of Ubiquitin Bound to Classes of Deubiquitinases

Ubiquitin is a small 76 amino acid post translational modifying protein that forms
chains from linkages of multiple ubiquitin via an isopeptide bond between the C-terminus
of one ubiquitin and a free amine of the other ubiquitin. Each Deubiquitinating enzyme
(DUB) however cannot cleave every type of diubiquitin chain due to structural
characteristics of both the ubiquitin and the DUB. There are two categories of DUBs
cysteine proteases and metalloproteases, within those are a subset of classes of DUBs:
Ubiquitin Carboxy Terminal Hydrolases (UCH), Ubiquitin specific proteases (USP),
Ovarian Tumor proteases (OTU), Jab1/Mov34/Mpr1 Pad1 N-terminal+ (JAMM), and
Machado-Josephin Domain proteases (MJD). Each of these classes have different
characteristics for their deubiquitination activities. The activity of deubiquitinating
enzymes is related to their affinity for ubiquitin which itself consists of a number of
factors such as structure of the substrate, charge exposure, area of collision, as well as
other factors. A simplistic version of a binding affinity model contains solvent accessible
surface area and a contribution from the structure of the substrate. In these studies we
performed a survey on ubiquitin bound to different classes of DUBs by comparing the
buried surface area of the ubiquitin bound structures and by comparing the differences of
the structure of bound ubiquitin relative to free ubiquitin.
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C.2

Obtaining the Structures of Bound Ubiquitin

Using the search tool on the Protein Database (PDB), as of July 2014, with
“ubiquitin” as the search term, all structures that contained ubiquitin were downloaded
then separated into categories based on ubiquitin binding protein. Within the main
category of DUBs and subcategories of classes of DUBs: USP, UCH, OTU, JAMM, and
MJD.

C.3

Buried Surface Area

In order to calculate the buried surface area, first the Solvent Accessible Surface
Area (ASA) of each of the three components the DUB alone, the bound ubiquitin alone,
and the complex of the Dub and the ubiquitin was obtained using the Solvent Accessible
Surface Area function associated with PyMol version 1.7.0.3. This was done on a per
ubiquitin basis if more than one ubiquitin was bound to the DUB. These were each
plotted on a bar graph by the Class of DUB.

Buried Surface Area = (ASA of protein + ASA of ubiquitin) -ASA of complex
Equation 1 Buried Surface Area Calculation Using Accessible Surface Areas.

The buried surface area for each of the different classes of DUBs were compared
with one another, a significant difference was mainly seen in the USP class when
compared to any of the other classes of DUBs. (Figure C.1)
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Figure C.1 Bar Graph Comparing the Buried Surface Area of the Classes of
DUBs. Buried Surface Area (y-axis) and each bound ubiquitin by class of enzyme
(x-axis).

C.4

Calculation of Differences in Distances

The Ubiquitin from each of the bound structures was transferred to its own file
removing the water and ubiquitin binding protein. First superimposition was used to
detect differences in the bound ubiquitin from the free ubiquitin. The function on its own
allowed for the removal of data for residues that were outside of a benchmark. In order
to prevent this occurrence, one round of the superimposition function was used, this
allowed for the presence of all residues. The superimposition function contains another
function to determine the root mean squared deviation (RMSD) between the
superimposed structure and the target ubiquitin. These values were obtained for each
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residue of the free ubiquitin that corresponded to the target ubiquitin. This gave values
that were still from a ubiquitin that was not well fit. In an attempt to negate the
complications with the fitting from the alignment, another method was developed for
analyzing the differences in distances of the ubiquitin molecules. In this method,
differences in the distances relative to a reference point were used to obtain distances
using the reference point of one residue to all of the other residues. This would be done
for each residue in a sequential method until all of the residues were analyzed. This
information was output into a grid comprising of the reference point is each row and the
iterating sample residue is each column. The output was transferred to a statistical
software to later be used for comparison to free ubiquitin. This same program was used
for free ubiquitin as well and the data was transferred to the same software. A table was
then made for the differences between the target ubiquitin and the free ubiquitin using.
(Equation 2) These data were then plotted on a graph with the difference on the y-axis
and the residue on the x-axis.

Difference of the Distance = (distance of sample residue from K48 of
sample ubiquitin) – (distance of sample residue from K48 of free
ubiquitin)
Equation 2 Difference of the Distances Using the Same Ubiquitin
Molecule as the Base.

These were performed for two varieties of distances 1) for the distance of the αcarbon of the reference residue on the ubiquitin to the α-carbon of the sample residue on
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the ubiquitin (α-C to α-C) and 2) for the average distance from the α-carbon of the
reference residue on the ubiquitin to the average of the distances to all of the atoms of the
sample residue of the ubiquitin (α-C to Average).
α-C to α-C: Differences between classes of DUBs were seen in the α-C to α-C
graphs though they only showed the differences in the structure of the backbone which
was providing informative minimal information. However, this was not relevant in
determining effects on the interaction of the binding interface of two proteins. (Figure
C.2)
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Figure C.2 Difference in Distances for K48 as Reference Using α-C to α-C
Method for Average Each Class. Differences in distances (y-axis) sample
residue (x-axis) the results are the average results for each class.
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α-C to Average: The differences between the α-C to average graphs gave a more
relevant difference for the interactions between the binding interface of two binding
proteins due to that accommodation of the side chain interactions. (Figure C.3)
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Figure C.3 Difference in Distances for K48 as Reference Using α-C to Average
Method for Each Class. Differences in distances (y-axis) sample residue (xaxis) the results are the average results for each class.
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C.5

Original RMSD_b Program Python Code
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C.6

RMSD_b for α-C to α-C Program Python Code
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C.7

RMSD_b for α-C to Average Program Python Code
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